Bryce Point Capital LLC acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 21,950 shares of the health services provider's stock, valued at approximately $1,639,000.
Other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in shares of Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after acquiring an additional 158 shares during the period. Eastern Bank acquired a new position in Maximus during the fourth quarter worth $29,000. V Square Quantitative Management LLC boosted its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares in the last quarter. R Squared Ltd acquired a new stake in Maximus in the fourth quarter valued at $54,000. Finally, IFP Advisors Inc increased its position in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.
Maximus Price Performance
Maximus stock traded down $2.26 during mid-day trading on Monday, hitting $66.40. 200,672 shares of the company were exchanged, compared to its average volume of 688,957. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a market capitalization of $3.76 billion, a P/E ratio of 14.28 and a beta of 0.68. The business's 50 day simple moving average is $69.16 and its two-hundred day simple moving average is $77.12. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. Maximus's dividend payout ratio is presently 25.81%.
Wall Street Analyst Weigh In
Several research firms recently commented on MMS. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective on the stock in a research report on Thursday, January 2nd. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th.
View Our Latest Analysis on Maximus
Insider Buying and Selling
In other news, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.